Alvotech Correlations
ALVO Stock | USD 12.99 0.21 1.64% |
The current 90-days correlation between Alvotech and Assertio Therapeutics is 0.04 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alvotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alvotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Alvotech Correlation With Market
Good diversification
The correlation between Alvotech and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and DJI in the same portfolio, assuming nothing else is changed.
Alvotech |
Moving together with Alvotech Stock
Moving against Alvotech Stock
0.75 | AMCCF | Amcor plc | PairCorr |
0.68 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.64 | APVO | Aptevo Therapeutics | PairCorr |
0.55 | INVA | Innoviva | PairCorr |
0.33 | JNJ | Johnson Johnson | PairCorr |
0.75 | HDVTY | Henderson Investment | PairCorr |
0.64 | UIS | Unisys Earnings Call This Week | PairCorr |
0.32 | ORGN | Origin Materials | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Alvotech Stock performing well and Alvotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alvotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ITCI | 1.76 | 0.60 | 0.40 | (11.38) | 0.88 | 2.51 | 34.42 | |||
CTLT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
AMPH | 1.39 | (0.66) | 0.00 | (1.09) | 0.00 | 2.13 | 10.11 | |||
ASRT | 2.73 | 0.04 | 0.01 | 0.47 | 2.86 | 5.95 | 21.93 | |||
ANIP | 1.37 | (0.06) | 0.00 | (0.09) | 0.00 | 2.64 | 7.45 | |||
ALKS | 1.43 | 0.34 | 0.23 | 0.50 | 1.22 | 4.82 | 7.97 | |||
RDY | 1.14 | (0.16) | 0.00 | (0.50) | 0.00 | 1.90 | 10.15 | |||
COLL | 1.83 | (0.10) | 0.00 | (0.27) | 0.00 | 3.07 | 17.80 | |||
PCRX | 2.31 | 0.63 | 0.24 | 6.11 | 2.10 | 5.32 | 18.06 |
Alvotech Corporate Management
Christina Siniscalchi | Interim Officer | Profile | |
Ming Li | Chief Officer | Profile | |
Sandra Casaca | Chief Officer | Profile | |
RoseMarie Ohlsson | Chief Officer | Profile | |
Anil Okay | Chief Officer | Profile | |
Giedrius Zunda | Chief Officer | Profile | |
Sean Gaskell | Chief Officer | Profile |